Gopinath Nageshwaran

ORCID: 0000-0002-2682-381X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 epidemiological studies
  • Immune responses and vaccinations
  • Acute Myocardial Infarction Research
  • Vaccine Coverage and Hesitancy
  • Systemic Lupus Erythematosus Research
  • Electrodeposition and Electroless Coatings
  • Cardiovascular Issues in Pregnancy
  • Neurological Complications and Syndromes
  • RNA Interference and Gene Delivery
  • Healthcare Quality and Management
  • Adrenal Hormones and Disorders
  • Corporate Taxation and Avoidance
  • Molecular Biology Techniques and Applications
  • Computational Drug Discovery Methods
  • Pregnancy and preeclampsia studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Pandemic Impacts
  • Data-Driven Disease Surveillance
  • Hormonal Regulation and Hypertension
  • Viral Infections and Immunology Research
  • Healthcare Policy and Management
  • Cardiac Imaging and Diagnostics
  • Electrochemical Analysis and Applications
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiovascular Function and Risk Factors

Sanofi (Mexico)
2020

AstraZeneca (United Kingdom)
2015

AstraZeneca (India)
2014-2015

BackgroundData on COVID-19-induced disruption to routine vaccinations in the South-East Asia and Western Pacific regions (SEAR/WPR) have been sparse. This study aimed quantify impact of COVID-19 by country, antigen, sector (public or private), up 1 June 2020, identify reasons for possible solutions.MethodsSanofi Pasteur teams from 19 countries SEAR/WPR completed a structured questionnaire reporting disruptions 13–19 routinely delivered antigens per based sales data, government reports,...

10.1016/j.lanwpc.2021.100140 article EN cc-by The Lancet Regional Health - Western Pacific 2021-04-21

Background: Although mRNA vaccines have the potential to be developed and deployed rapidly combat infectious diseases, ideal method of administration boosting schedule strategy for generating optimal immunogenicity is an area active research. We compared immune responses resulting from different schedules prime–boost either ipsilaterally or contralaterally in relation initial vaccine dose. Methods: Influenza hemagglutinin (HA) was used as a model antigen vaccination regimens mice using both...

10.3390/vaccines13030263 article EN cc-by Vaccines 2025-03-01

Background: Data on COVID-19-induced disruption to routine vaccinations in the South-East Asia and Western Pacific regions (SEAR/WPR) have been sparse. This study aimed quantify impact of COVID-19 by country, antigen, sector (public or private), up 1 June 2020, identify reasons for possible solutions. Methods: Sanofi Pasteur teams from 19 countries SEAR/WPR completed a structured questionnaire reporting disruptions 13–19 routinely delivered antigens per based sales data, government reports,...

10.2139/ssrn.3754264 article EN SSRN Electronic Journal 2020-01-01

O ST E R A B C T S function. To screen the widest possible population, we are obliged to use non-invasive investigation techniques. Methods: Study population of 975 male self-supporting patients, complaining thoracic pain, divided in 495 healthy subjects (HS) and 480 coronary patients (CP), subdivided three age groups: 40-59y; 60-79y; 80-99y. Measurement by speckle-tracking echocardiography “global longitudinal peak systolic strain average (GLPSSavg) left ventricle, “average 5 myocardial...

10.1016/j.ihj.2014.10.022 article EN publisher-specific-oa Indian Heart Journal 2014-11-01
Coming Soon ...